Geftinat 250 mg Tablet About
Spotlight your oncology care with Geftinat 250 mg Tablet, a sizzling pharmaceutical innovation featuring the dominant active ingredient, Gefitinib. Designed as a top-notch solution for non-small cell lung cancer (NSCLC), this astounding medication ensures reliable results across clinical, hospital, and personal settings. Each strip pack contains 30 orally-administered tablets, offering exceptional access to advanced cancer treatment. Only available via prescription, Geftinat 250 mg exemplifies quality and efficacy-making it the trusted choice for exporters, suppliers, and traders throughout India. Elevate your therapeutic standards with every dose of Geftinat.
Versatile Application & Standout Features of Geftinat 250 mg Tablet
Geftinat 250 mg Tablet finds its application across clinical, hospital, and personal environments, ensuring widespread access to advanced NSCLC management. Engineered for oral administration, its special features include a convenient strip pack (1x30) and a precisely measured 250 mg dosage, promoting accurate treatment. The top-quality API formulation assures consistent performance on various application surfaces such as hospital dispensaries, healthcare centers, and at-home care. Designed for efficiency, it elevates patient adherence and therapeutic outcomes.
Astounding Domestic Reach & Efficient Supply of Geftinat 250 mg Tablet
The main domestic market for Geftinat 250 mg Tablet captivates every major healthcare segment across India. Renowned for its prompt arrival to customers, the streamlined outlay process guarantees minimal wait times and steady restocking. We proudly offer flexible supply ability to meet high-volume demands, ensuring consistent availability for clinical, hospital, and personal use. Delivery time is optimized for efficiency, providing top-notch customer satisfaction with every order.
FAQ's of Geftinat 250 mg Tablet:
Q: How should Geftinat 250 mg Tablet be taken?
A: Geftinat 250 mg Tablet is intended for oral administration. It should be taken as directed by a physician, typically once daily, with or without food. Adherence to the prescribed dosage and schedule is essential for optimal results.
Q: What is the primary benefit of using Geftinat 250 mg Tablet?
A: The primary benefit of Geftinat 250 mg Tablet is its efficacy in treating non-small cell lung cancer (NSCLC), delivering targeted therapy to inhibit cancer cell growth. Its advanced API formulation enhances treatment outcomes and patient well-being.
Q: When should Geftinat 250 mg be prescribed?
A: Geftinat 250 mg should be prescribed by healthcare professionals specifically for patients diagnosed with non-small cell lung cancer (NSCLC), in cases where gefitinib therapy is indicated. A valid prescription is required for its purchase and use.
Q: Where can Geftinat 250 mg Tablet be accessed or purchased?
A: Geftinat 250 mg Tablet is available through authorized exporters, suppliers, and traders across India. It requires a valid prescription and is dispensed by hospitals, clinics, and licensed pharmacies for medical use.
Q: What are the key features that make Geftinat 250 mg stand out?
A: Key features of Geftinat 250 mg include its dominant 250 mg dosage, oral tablet form in a 1x30 strip pack, advanced gefitinib formulation, and its application versatility across clinical and personal settings. It delivers top-notch, reliable cancer care.